KH607

· Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KH607, covering 2025-07-31 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder [Phase 2]

See pricing